Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Single Cell Genomics Markets – Forecasts by End User & Technology – With Executive & Consultant Guides, Including…
EDMONTON, Alberta–(BUSINESS WIRE)–The BioAlberta Board of Directors announced today that Mr. Robb Stoddard has been appointed BioAlberta’s new President and…
Current NATESTO® supply to the United States remains unaffected TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP, OTCQB:ASPCF) today provided an update on…
Acquisition of U.S. Laboratory and Lung Nodule Malignancy Risk Test Finalized BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc., today announced that it has…
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to developing and commercializing next-generation medicines to improve…
DUBLIN–(BUSINESS WIRE)–The “Innovations in Biomarker Analytics” report has been added to ResearchAndMarkets.com’s offering. This global research service provides extensive information…
NEW YORK–(BUSINESS WIRE)–$BMY–Bristol-Myers Squibb Company (NYSE:BMY) (“Bristol-Myers Squibb”) announced today the extension of the expiration date of the offers to…
DUBLIN–(BUSINESS WIRE)–The “Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025” report has been added to ResearchAndMarkets.com’s…
Full Mirvetuximab Soravtansine Phase 3 FORWARD I and Initial Phase 1b FORWARD II Triplet Data Presented at ESMO Phase 3…
Lowers 2019 Earnings Guidance PHOENIX–(BUSINESS WIRE)–Magellan Health, Inc. (NASDAQ: MGLN) today announced financial results for the third quarter ended September…